Zydus Cadila

Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibodies cocktail to neutralise COVID infection

Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.